Amyloid PET predicts longitudinal functional and cognitive trajectories in a heterogeneous cohort.

Amyloid positron emission tomography (PET) is increasingly available for diagnosis of Alzheimer`s disease (AD); however, its practical implications in heterogenous cohorts are debated.